Neurogene Inc. · SWB:UU8

Neurogene Inc. financial statements

Neurogene Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0925.0K00025.0M
Cost of revenue3.19M3.25M3.26M3.20M42.3M1.82M340.0K
Gross profit-3.19M-2.32M-3.26M-3.20M-42.3M-1.82M-340.0K25.0M
Research and development75.0M60.9M44.4M47.5M39.2M24.3M4.42M41.8M36.3M28.4M
Selling, general and administrative28.3M22.6M11.2M9.01M8.27M
Operating income-103.3M-82.6M-55.6M-56.5M-60.7M-33.7M-71.0M-32.6M-51.1M-37.6M
Depreciation and amortization3.04M3.19M3.26M3.20M1.31M785.0K340.0K289.0K360.0K1
EBITDA-100.3M-79.4M-52.3M-53.3M-59.4M-32.9M-70.6M-32.3M-50.8M-37.6M
Interest expense5.00K12.0K12.0K2.00K01.00K4.00K4.00K1.00K
Income before tax-90.4M-75.1M-36.3M-55.2M-60.7M-33.3M-69.4M-31.6M-50.2M-37.0M
Income tax00-16.0K-5.00K17.0K-1168.1K-10
Net income-90.4M-75.1M-36.3M-55.2M-60.7M-33.3M-69.4M-31.6M-50.2M-37.0M
Earnings per share, basic-4.24-4.28-2.83-1.04-1.10-0.64-2.57-1.34-2.14-1.96
Earnings per share, diluted-4.24-4.28-1.04-1.10-0.64-2.57-1.34-2.14-1.96

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents103.8M136.6M148.2M82.0M142.5M192.6M143.1M76.9M52.0M32.3M
Short-term investments165.2M175.8M48.9M0056.1M70.8M
Receivables648.0K600.0K990.0K790.0K
Inventory1.50M1.08M1.91M
Current assets271.8M315.9M200.3M84.7M144.0M194.5M143.6M77.2M108.8M103.5M
Property, plant and equipment12.8M15.4M17.2M20.1M6.45M3.57M2.06M400.0K905.0K849.0K
Total assets288.6M335.7M222.6M109.3M163.3M210.5M147.0M77.6M110.3M154.4M
Accounts payable1.95M1.34M2.60M625.0K5.63M1.32M1.60M702.0K
Current liabilities16.4M15.2M23.0M6.65M8.64M7.89M4.74M4.63M11.0M9.52M
Total debt9.89M12.4M16.3M4.69M6.43M12.1M1.21M6.00K33.0K47.0K
Total liabilities23.7M25.4M36.5M10.6M20.4M19.3M5.34M4.95M11.4M9.72M
Shareholders' equity264.9M310.4M186.0M-145.7M-91.9M191.2M141.7M72.7M98.9M144.7M
Shares outstanding15.5M14.9M12.8M042.5M42.2M38.0M23.5M23.5M23.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-77.2M-70.6M-51.4M-52.8M-47.6M-24.6M-15.4M-31.6M-44.7M-30.2M
Capital spending-1.18M-808.0K-321.0K-2.23M-3.26M-2.22M-879.0K-49.0K-494.0K-713.0K
Free cash flow-78.4M-71.4M-51.7M-55.1M-50.8M-26.8M-16.3M-31.6M-45.2M-30.9M
Cash from investing14.0M-125.3M25.6M-2.23M-3.26M-2.22M-688.0K56.0M64.0M-48.1M
Cash from financing30.4M184.1M92.5M66.5M732.0K77.1M82.2M570.0K423.0K71.1M
Change in cash-32.7M-11.8M66.7M11.5M-50.1M50.3M66.2M24.9M19.7M-7.22M